These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33629793)

  • 1. Successful use of recombinant activated factor VII administered via automated bolus pump following emergency laparoscopic appendectomy in a patient with mild congenital FVII deficiency: Case report.
    Perkins H; Klaassen RJ
    Pediatr Blood Cancer; 2021 Aug; 68(8):e28974. PubMed ID: 33629793
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant factor VIIa, its clinical properties, and the tissue factor pathway of coagulation.
    Bosinski TJ; El Solh AA
    Mini Rev Med Chem; 2006 Oct; 6(10):1111-7. PubMed ID: 17073711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIIa replacement therapy in factor VII deficiency.
    Brummel Ziedins K; Rivard GE; Pouliot RL; Butenas S; Gissel M; Parhami-Seren B; Mann KG
    J Thromb Haemost; 2004 Oct; 2(10):1735-44. PubMed ID: 15456484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of coagulant activity of factor VII and activated factor VII activity assays when used for determination of recombinant activated factor VII levels in plasma.
    Scharling B; Nielsen GG; Klitgaard T; Skovsted TA; Møss J; Segel S; Larsen LF
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):677-84. PubMed ID: 17890956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
    Mariani G; Konkle BA; Ingerslev J
    Haemophilia; 2006 Jan; 12(1):19-27. PubMed ID: 16409171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new perspective on perioperative coagulation management in a patient with congenital factor VII deficiency: A case report.
    Sun Y; Jia L; Yang Z; Chen W
    Medicine (Baltimore); 2018 Nov; 97(44):e12776. PubMed ID: 30383632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between recombinant activated factor VII (Aryoseven) and Novoseven in patients with congenital factor VII deficiency.
    Faranoush M; Abolghasemi H; Toogeh G; Karimi M; Eshghi P; Managhchi M; Hoorfar H; Dehdezi BK; Mehrvar A; Khoeiny B; Kamyar K; Heshmat R; Baghaeipour MR; Mirbehbahani NB; Fayazfar R; Ahmadinejad M; Naderi M
    Clin Appl Thromb Hemost; 2015 Nov; 21(8):724-8. PubMed ID: 24651301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful prophylaxis against intracranial hemorrhage using weekly administration of activated recombinant factor VII in a newborn with severe factor VII deficiency.
    Farah RA; Hamod D; Melick N; Giansily-Blaizot M; Sallah S
    J Thromb Haemost; 2007 Feb; 5(2):433-4. PubMed ID: 17109737
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency.
    Gorkom BL; Holme PA; Joch C; Rogosch T; Feussner A; McKeand W; Roberts J; van Heerde W
    Hematology; 2020 Dec; 25(1):17-25. PubMed ID: 31852380
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency.
    Tcheng WY; Donkin J; Konzal S; Wong WY
    Haemophilia; 2004 May; 10(3):295-8. PubMed ID: 15086331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic treatment of a small child with severe factor VII deficiency using repeat dosing from a single vial of recombinant activated factor VII.
    Michaels LA; Philipp CS; Eisele J; Pappas H; Saidi P
    Pediatr Blood Cancer; 2007 Oct; 49(5):736-9. PubMed ID: 16317734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VII deficiency and its treatment in delivery with recombinant factor VII.
    Pehlivanov B; Milchev N; Kroumov G
    Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):237-8. PubMed ID: 15358473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients.
    van Geffen M; Mathijssen NC; Holme PA; Laros-van Gorkom BA; van Kraaij MG; Masereeuw R; Peyvandi F; van Heerde WL
    Thromb Res; 2013 Jul; 132(1):116-22. PubMed ID: 23731565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect.
    Morfini M; Batorova A; Mariani G; Auerswald G; Bernardi F; Di Minno G; Dolce A; Fede C; Giansily-Blaizot M; Ingerslev J; Martinowitz U; Napolitano M; Pinotti M; Schved JF;
    Thromb Haemost; 2014 Aug; 112(2):424-5. PubMed ID: 24763923
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant factor VIIa for the treatment of congenital factor VII deficiency.
    Hunault M; Bauer KA
    Semin Thromb Hemost; 2000; 26(4):401-5. PubMed ID: 11092215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of recombinant factor VIIa for hip surgery in a patient with factor-VII deficiency. A case report.
    Gopalan PK; Clohisy JC; Cashen AF; Eby CS
    J Bone Joint Surg Am; 2007 Feb; 89(2):389-91. PubMed ID: 17272455
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiency.
    Miyata N; Isaka M; Kojima H; Maniwa T; Takahashi S; Takamiya O; Ohde Y
    Gen Thorac Cardiovasc Surg; 2016 Mar; 64(3):177-80. PubMed ID: 25056454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII.
    Tokgoz H; Caliskan U; Lavigne-Lissalde G; Giansily-Blaizot M
    Haemophilia; 2012 Jan; 18(1):e25-7. PubMed ID: 21973016
    [No Abstract]   [Full Text] [Related]  

  • 20. Acquired isolated factor VII deficiency associated with severe bleeding and successful treatment with recombinant FVIIa (NovoSeven).
    Mullighan CG; Rischbieth A; Duncan EM; Lloyd JV
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):347-51. PubMed ID: 15166922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.